Markets

Market

News Details

(27/04/2026 19:10)

Astec Lifesciences posts Q4 net loss of Rs 7.78 cr

The company reported standalone net loss during the quarter stood at Rs 7.78 crore as compared to net loss of Rs 16.10 crore in the previous year quarter.

Net revenue of the company rose substantially by 32.70 per cent at Rs 158.62 crore in January-March quarter of this fiscal as against Rs 119.53 crore in the corresponding period last year.

During January-March quarter, operating expenses increased by 31.11 per cent to Rs 149.46 crore from Rs 114.00 crore in year ago period.

Other Income grew by 234.62 per cent at Rs 2.61 crore versus (Mar'25 Rs 0.78 crore).

Operating Profit surged by 65.94 per cent to Rs 9.16 crore as against Rs 5.52 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 25.11 per cent in March quarter.

Interest declined by 23.75 per cent y-o-y to Rs 7.93 crore, while Taxation decreased by 139.02 per cent at Rs -0.16 crore (Mar'25 Rs 0.41 crore).

Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.